Product reference

Retatrutide

Available for enquiry

An investigational triple agonist in clinical research programmes.

Retatrutide is studied at GLP-1, GIP and glucagon receptors. Mechanism and study outcomes are not marketing authorisation.

CAS number2381089-83-2

10 mg · €9115 mg · €12720 mg · €164

From €91

Indicative value — not an offer for sale

Evidence must be checkable

Current batch and analysis documentation is supplied after an approved enquiry.

Analytical identity confirmation with method and date.

Batch number, analysis date and product linkage.

Laboratory, method, measured value and verifiable source.

Go deeper

A source-led review of retatrutide's status, mechanism and the limits on interpretation.